A Leap Forward – All Oral Regimens Revolutionizing Multidrug-resistant Tuberculosis Treatment
Saved in:
| Main Author: | Durga Balagopalan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-07-01
|
| Series: | Journal of Advanced Lung Health |
| Online Access: | https://journals.lww.com/10.4103/jalh.jalh_23_25 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of a modified short all oral treatment regimen for rifampicin-multidrug resistant tuberculosis in Dominican Republic
by: María Rodríguez, et al.
Published: (2025-02-01) -
Bedaquiline and linezolid regimens for multidrug-resistant tuberculosis: a systematic review and meta-analysis
by: Mahdis Cheraghi, et al.
Published: (2025-03-01) -
Impact of all-oral bedaquiline-based shorter regimens in the treatment of drug-resistant tuberculosis: a systematic review and meta-analysis
by: Ming Liu, et al.
Published: (2025-04-01) -
Non-inferiority stepped wedge cluster randomized controlled trial on all-oral shorter regimens for rifampicin resistant/multidrug-resistant TB in Pakistan – a study protocol
by: Nida Khan, et al.
Published: (2025-05-01) -
End of treatment and 12-month post-treatment outcomes in patients treated with all-oral regimens for rifampicin-resistant tuberculosis in Ukraine: a prospective cohort study.
by: Vini Fardhdiani, et al.
Published: (2025-01-01)